Mechanistically, IL-17A/IL-17RA axis activation leads to TGF-β release and neutrophil-mediated fibrogenesis, thereby functionally coupling inflammatory and fibrotic pathways in IPF pathogenesis (Huangfu et al., 2023; Lorè et al., 2016). The gene discussed is IL17A; the disease is idiopathic pulmonary fibrosis.